Latest Headlines
-
Prokidney Announces Plans For New Cell Therapy Manufacturing Facility In North Carolina
6/13/2023
ProKidney Corp. (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients suffering from chronic kidney disease (CKD), today announced its agreement to purchase a 210,000 square foot facility and approximately 22 acres of land in Greensboro, N.C., to support the Company’s future commercial manufacturing needs for REACT®, its proprietary REnal Autologous Cell Therapy, currently in Phase 3 development for the treatment of diabetic CKD.
-
Qosina And Carolina Components Partner To Promote FlowLinX Bioprocessing Components
6/8/2023
Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is happy to announce its partnership with Carolina Components Group, a leading supplier of primary and support production materials for the pharmaceutical and biotech manufacturing industries.
-
Presentations, Roundtable Discussions, And Interviews: ISCT Paris 2023
6/8/2023
As a CDMO specializing in cell therapy manufacturing, BioCentriq was eager to participate in this event focused on cell and gene therapy translation, which takes an integrative approach across all stakeholders to tackle key topics ranging from translational research and preclinical development through clinical trials, regulatory approvals, commercialization, and the ultimate goal of patient access.
-
BioCentriq Hosts Cohort From Bpeace Pharma Maximizer Program
6/7/2023
BioCentriq had the great pleasure of hosting ten leaders from five different Salvadoran businesses who are participants in Bpeace’s Pharma Maximizer program.
-
BioCentriq, Kytopen Expand Partnership To Optimize CGT Manufacturing
6/6/2023
Learn how the extended partnership will expand therapeutic developers’ access to a leading non-viral cell engineering method by combining BioCentriq’s process development expertise with Kytopen’s Flowfect Discover™ platform.
-
IPS Appoints Jim Stephanou As New CEO
6/5/2023
IPS, a leading provider of architecture, engineering, procurement, construction management, and validation services for the life sciences sector, announces the appointment of Jim Stephanou as its new Chief Executive Officer (CEO) to lead the company into its next phase of growth.
-
Advanced Therapy Platform Helps Biotechs Reach Patients In Record Time
6/1/2023
Discover the platform designed to help early-stage biotech companies get to patients faster by using pre-existing processes and documentation, already qualified equipment, facilities and people, and other knowledge assets.
-
Novotech Sponsors BIO 2023 APAC Summit And The Endpoints Panel On Forging Biotech Ties With China
5/29/2023
Novotech, the leading Asia Pacific centred biotech CRO is sponsoring the BIO 2023 APAC Summit, and the Endpoints session on Forging New Biotech Ties with China.
-
Qosina Releases New 2023 Bioprocess Single-Use Components Catalog
5/26/2023
Qosina, a global supplier of OEM single-use components to the medical and bioprocess industries, is thrilled to announce the release of its new bioprocess components catalog, available in both print and digital formats.
- Novotech Sponsors Oncology Summit With eChina Health And Expert Panel On Drug Development Acceleration With Endpoints For ASCO 2023 5/26/2023